M Craen
Overview
Explore the profile of M Craen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tack L, Brachet C, Beauloye V, Heinrichs C, Boros E, De Waele K, et al.
Hum Reprod Open
. 2024 Dec;
2023(4):hoad047.
PMID: 39659563
Study Question: What is the long-term outcome of individuals born with bilateral testicular regression (BTR) in relation to its underlying etiology? Summary Answer: Statural growth and pubertal development are adequate...
2.
Beauloye V, Dhondt K, Buysse W, Nyakasane A, Zech F, De Schepper J, et al.
Orphanet J Rare Dis
. 2015 Sep;
10:106.
PMID: 26329144
Background: Children with Prader-Willi Syndrome (PWS) have been considered at risk for central adrenal insufficiency (CAI). Hypothalamic dysregulation has been proposed as a common mechanism underlying both stress-induced CAI and...
3.
Lagrou K, Froidecoeur C, Thomas M, Massa G, Beckers D, Craen M, et al.
Horm Res
. 2008 May;
69(6):334-42.
PMID: 18504392
Background/aims: Few data are available about parental concerns and psychosocial functioning of young children born small for gestational age (SGA) treated with growth hormone (GH). The present study focused on...
4.
Raes A, Matthys D, Donckerwolcke R, Craen M, Van Aken S, Vande Walle J
Acta Paediatr
. 2007 Feb;
96(4):548-51.
PMID: 17306011
Aim: To examine the relationship between filtration fraction and systemic vasculopathy, in normoalbuminuric insulin-dependent diabetic adolescents. Methods: We calculated filtration fraction from measured glomerular filtration rate and renal plasma flow...
5.
Lagrou K, Vanderfaeillie J, Froidecoeur C, Thomas M, Massa G, Tenoutasse S, et al.
Eur J Endocrinol
. 2007 Feb;
156(2):195-201.
PMID: 17287409
Objective And Design: Children born small for gestational age (SGA) are not only at risk for short stature, but also for neurodevelopmental and behavioral problems. In this study, we analyzed...
6.
Vits L, Beckers D, Craen M, De Beaufort C, Vanfleteren E, Dahan K, et al.
Clin Genet
. 2006 Sep;
70(4):355-9.
PMID: 16965331
No abstract available.
7.
Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon J, Craen M, et al.
Arch Dis Child
. 2005 Feb;
90(3):267-8.
PMID: 15723912
The age at diagnosis of 242 girls with Turner syndrome (TS) treated in Belgium with growth hormone between 1991 and 2002 was evaluated. The median (range) age at diagnosis was...
8.
Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon J, Craen M, et al.
Horm Res
. 2004 Aug;
62(4):161-7.
PMID: 15297800
Background: Most girls with Turner syndrome (TS) are intensively followed by paediatricians, but are lost to follow-up when they reach adulthood. To gain insight into the adult medical and psychosocial...
9.
Thomas M, Massa G, Craen M, de Zegher F, Bourguignon J, Heinrichs C, et al.
Eur J Endocrinol
. 2004 Jul;
151(1):67-72.
PMID: 15248824
Objective: Since the availability of recombinant human growth hormone (rhGH) all children with growth hormone deficiency (GHD) living in Belgium are offered rhGH treatment after approval by a peer-review board....
10.
Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon J, Craen M, et al.
J Clin Endocrinol Metab
. 2003 Sep;
88(9):4168-74.
PMID: 12970282
Although it has been well established that GH treatment increases final height (FH) in girls with Turner syndrome (TS), the optimal ages to start GH therapy and introduce estrogens for...